Rationale and Prospects of Targeting Bacterial Two-component Systems for Antibacterial Treatment of Cystic Fibrosis Patients

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|18|6|687-695

ISSN： 1389-4501

Source： Current Drug Targets, Vol.18, Iss.6, 2017-03, pp. : 687-695

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of bacterial two-component signalling systems

By Macielag M.J.   Goldschmidt R.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2351-2369

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic Optimisation of Antibacterial Treatment in Patients with Cystic Fibrosis: Current Practice and Suggestions for Future Directions

By Touw D.J.  

Clinical Pharmacokinetics, Vol. 35, Iss. 6, 1998-12 ,pp. : 437-459

Adis International

Access to resources Recommend Favorite

Targeting Molecular Chaperones for the Treatment of Cystic Fibrosis: Is It a Viable Approach?

By  

Current Drug Targets, Vol. 16, Iss. 9, 2015-01 ,pp. : 958-964

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting neutrophil elastase in cystic fibrosis

By Kelly Emer   Greene Catherine M   McElvaney Noel G  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 2, 2008-02 ,pp. : 145-157

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Root Cause of Cystic Fibrosis

By  

Current Drug Targets, Vol. 16, Iss. 9, 2015-08 ,pp. : 933-944

Bentham Science Publishers

Access to resources Recommend Favorite